RCM
RA Capital Management’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,809,404
| Closed | -$45.7M | – | 81 |
|
|
2024
Q1 | $45.7M | Hold |
6,809,404
| – | – | 0.58% | 44 |
|
|
2023
Q4 | $62.1M | Hold |
6,809,404
| – | – | 0.97% | 26 |
|
|
2023
Q3 | $37.6M | Sell |
6,809,404
-5,488,317
| -45% | -$30.3M | 0.74% | 37 |
|
|
2023
Q2 | $105M | Sell |
12,297,721
-1,083,333
| -8% | -$9.25M | 1.98% | 12 |
|
|
2023
Q1 | $123M | Hold |
13,381,054
| – | – | 2.78% | 8 |
|
|
2022
Q4 | $137M | Hold |
13,381,054
| – | – | 2.77% | 10 |
|
|
2022
Q3 | $197M | Hold |
13,381,054
| – | – | 4.2% | 3 |
|
|
2022
Q2 | $144M | Hold |
13,381,054
| – | – | 3.83% | 3 |
|
|
2022
Q1 | $144M | Buy |
13,381,054
+3,774,026
| +39% | +$40.7M | 3.15% | 4 |
|
|
2021
Q4 | $157M | Hold |
9,607,028
| – | – | 2.76% | 6 |
|
|
2021
Q3 | $206M | Buy |
+9,607,028
| New | +$206M | 2.85% | 6 |
|